Insights

In this video, Samantha Meltzer-Brody, MD, MPH, discusses the use of brexanolone and zuranolone, novel neurosteroids for treating postpartum depression, focusing on their mechanisms, rapid efficacy, and clinical trial...

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain...

Ilse Wiechers presents an in-depth exploration of advanced neuromodulation techniques for treating difficult-to-treat depression. Discover cutting-edge research, clinical applications, and the latest insights on personalized brain stimulation approaches aimed...

Dr. Lisa M. Harding discusses the latest advancements in neuroimaging and personalized treatment strategies for difficult-to-treat depression. Learn about cutting-edge research, diagnostic tools, and targeted therapies that are paving...

Evaluating different domains of negative symptoms separately to better understand their impact on functional outcomes, particularly cognitive symptoms, is important in the treatment of patients with schizophrenia, especially intervening...

One of the central gaps that can affect treatment adherence for individuals with schizophrenia is side effects. Adverse events can lead to substantial impacts across all aspects of daily...